Clinical trial
Randomised Induction and Post Induction Therapy in Older Patients (≥61 Years of Age) With Acute Myeloid Leukemia (AML) and Refractory Anemia With Excess Blasts (RAEB, RAEB-t)
NCT00121303 is registered in ClinicalTrials.gov with Stichting Hemato-Oncologie voor Volwassenen Nederland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Induction and Post Induction Therapy in Older Patients (≥61 Years of Age) With Acute Myeloid Leukemia (AML) and Refractory Anemia With Excess Blasts (RAEB, RAEB-t)
- Lead sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- June 30, 2016
- Enrollment
- 600 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.